BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16807550)

  • 1. Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion.
    Shearer GC; Kaysen GA
    Kidney Int; 2006 Aug; 70(4):647-53. PubMed ID: 16807550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
    Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
    Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms.
    Shearer GC; Kaysen GA
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S119-22. PubMed ID: 11158876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression of lipoprotein lipase in experimental nephrosis.
    Liang K; Vaziri ND
    J Lab Clin Med; 1997 Oct; 130(4):387-94. PubMed ID: 9358077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels.
    Wang L; Shearer GC; Budamagunta MS; Voss JC; Molfino A; Kaysen GA
    Kidney Int; 2012 Nov; 82(9):990-9. PubMed ID: 22785171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria.
    Ni Z; Vaziri ND
    Biochim Biophys Acta; 2003 Jul; 1638(2):129-37. PubMed ID: 12853118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1204-9. PubMed ID: 9028578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
    Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
    Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
    Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
    Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective lipolysis persists in hearts of rats with heymann nephritis in the absence of nephrotic plasma.
    Kaysen GA; Pan XM; Couser WG; Staprans I
    Am J Kidney Dis; 1993 Jul; 22(1):128-34. PubMed ID: 8322775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
    Rodrigues B; Severson DL
    Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of hepatic lipase expression in experimental nephrotic syndrome.
    Liang K; Vaziri ND
    Kidney Int; 1997 Jun; 51(6):1933-7. PubMed ID: 9186885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures.
    Chajek-Shaul T; Halimi O; Ben-Naim M; Stein O; Stein Y
    Biochim Biophys Acta; 1989 Nov; 1014(2):178-83. PubMed ID: 2554975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fate of rat heart endothelial lipoprotein lipase.
    Chajek-Shaul T; Bengtsson-Olivecrona G; Peterson J; Olivecrona T
    Am J Physiol; 1988 Sep; 255(3 Pt 1):E247-54. PubMed ID: 3421325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.
    Davies RW; Staprans I; Hutchison FN; Kaysen GA
    J Clin Invest; 1990 Aug; 86(2):600-5. PubMed ID: 2384606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen effects on triglyceride metabolism in analbuminemic rats.
    Shearer GC; Joles JA; Jones H; Walzem RL; Kaysen GA
    Kidney Int; 2000 Jun; 57(6):2268-74. PubMed ID: 10844597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional regulation of binding sites for lipoprotein lipase in rat heart.
    Ruge T; Bergö M; Hultin M; Olivecrona G; Olivecrona T
    Am J Physiol Endocrinol Metab; 2000 Feb; 278(2):E211-8. PubMed ID: 10662704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a heparin-releasable lipoprotein lipase binding protein from endothelial cells.
    Sivaram P; Klein MG; Goldberg IJ
    J Biol Chem; 1992 Aug; 267(23):16517-22. PubMed ID: 1644832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.